Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
9.18
-0.43 (-4.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
Omeros Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
198
Market Cap
531.98M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
OMER News
- 2 days ago - Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA - Business Wire
- 8 days ago - Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings - Business Wire
- 12 days ago - Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program - Business Wire
- 5 weeks ago - Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint - Business Wire
- 2 months ago - Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges - Benzinga
- 2 months ago - Omeros' Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA - Business Wire
- 2 months ago - Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting - Business Wire
- 2 months ago - Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting - Business Wire